{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Ravi Sirdeshmukh"}, {"accession": "MS:1000589", "name": "contact email", "value": "ravisirdeshmukh@gmail.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Institute of Bioinformatics"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Dr. Ravi Sirdeshmukh"}, {"accession": "MS:1000589", "name": "contact email", "value": "ravisirdeshmukh@gmail.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Institute of Bioinformatics, Bangalore - 560066, India"}]}], "datasetFiles": [{"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/08/PXD014111/Glioma_Nuclear_prep_Gradeall_4plex.msf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/08/PXD014111/Glioma_Nuclear_prep_Gradeall_4plex.raw"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/08/PXD014111/Glioma_Nuclear_prep_Gradeall_repeat_4plex.msf"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/08/PXD014111/Glioma_Nuclear_prep_Gradeall_repeat_4plex.raw"}], "description": "Glioma tumors arise from normal glial cells (astrocytes). Gliomas are morphologically and clinically classified into four malignancy grades as Grade I, II, III and IV. Grade I and II comprise low grade gliomas that grow slowly, are well differentiated and have a better prognosis and survival compared to grades III and IV. In contrast, grade III-IV lack endothelial proliferation and are highly vascular with a tendency to infiltrate and have areas of extensive necrosis and hypoxia. In the present study, we used iTRAQ (isobaric tags for relative and absolute quantitation) - based quantitative proteomic approach followed by online liquid chromatography and high resolution tandem mass spectrometry (LC-MS/MS) to identify differential nuclear proteins enriched with transcriptional regulatory function from three different grades of astrocytoma tumors (WHO Grade II, III and IV) compared to control.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/08/PXD014111"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD014111"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD014111"}], "instruments": [{"accession": "MS:1001742", "name": "LTQ Orbitrap Velos"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Glioma, diffused astrocytoma, anaplastic astrocytoma, Glioblastoma, sub cellular fractionation, nuclear proteins, iTRAQ, transcription factor, transcription regulatory proteins"}], "modifications": [{"accession": "MOD:01499", "name": "iTRAQ4plex-116 reporter+balance reagent acylated residue"}, {"accession": "MOD:01153", "name": "methylthiolated residue"}, {"accession": "MOD:00425", "name": "monohydroxylated residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "31358880"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Gupta MK, Polisetty RV, Sharma R, Ganesh RA, Gowda H, Purohit AK, Ankathi P, Prasad K, Mariswamappa K, Lakshmikantha A, Uppin MS, Sundaram C, Gautam P, Sirdeshmukh R. Altered transcriptional regulatory proteins in glioblastoma and YBX1 as a potential regulator of tumor invasion. Sci Rep. 2019 9(1):10986"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "iTRAQ-based quantitative proteomic analysis of nuclear fractions of glioma (WHO grade II, III and IV) tissues to identify altered transcriptional regulatory proteins"}